In a new study, an experimental obesity drug from Novo Nordisk called CagriSema allowed people to lose more than 20% of their ...

Alzheimer's, addiction, cardiovascular diseases, kidney disorders, sleep apnoea, diabetes, obesity, and overweight.

EUROPE’S Stoxx 600 index clocked its first weekly advance in three on Friday (Dec 27), boosted by advancing healthcare and ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Loomis Sayles, an investment management company, released its “International Growth Fund” third quarter 2024 investor letter.

Whether this year’s big job commitments sink or swim will be known in time. But for now, let’s explore the dreams.

Whether this year’s big job commitments sink or swim will be known in time. But for now, let’s explore the dreams.

Amazon may be known for its retail and tech chops, but the company has also built a strong operation in the healthcare realm over the last several years.

Weight-loss treatments are on the cusp of a revolution, and could benefit large numbers of Indians after the main patent ...

European stocks were higher on Friday, as markets in the region reopened following a closure for the Christmas holiday.